Abstract
Objective Retinal vein occlusion (RVO) is the second most common retinal vascular diseases after diabetic retinopathy. Delay in detection and treatment can result in irreversible visual impairment and blindness. The aim of this study was to assess the magnitude and clinical pattern of patients with RVO presentedd to the retina clinic at University of Gondar Tertiary Eye Care and Training Centre
Methods A hospital based Cross-sectional study was conducted from October 2017 – March 2018 and patients of all ages with RVO seen at our retina clinic during the study period were reviewed. Pertinent ophthalmic history, ophthalmic clinical examination and laboratory tests were done including detailed funducopy for each patient. Data were collected with structured questionnaire, entered to SPSS version 20 and analysed.
Result A total of 38 eyes of 36 new patients with RVOs were seen during the six month study period and reviewed. Twenty four (66%) study patients were males and the mean age was 58 ± 10.87 years. Thirty four (94.4%) patients had unilateral disease. Nineteen (52.78%) had Central retinal vein occlusion (CRVO), 13 (36.11%) had branch retinal vein occlusion (BRVO) and 4 (11.11%) had hemispheric retinal vein occlusion (HRVO). Glaucoma was the commonest risk factor seen in 17 (47.22%) patients followed by systemic hypertension 10 (27.78%) and diabetes mellitus 8 (22%). The commonest complications encountered were macular edema, retinal or optic disc neovascularization and neovascular glaucoma seen in 15 (41.67%), 11 (30.5%) and 4 (11.11%) patients respectively. Over a third of patients 15 (41.67%) presented to our retina clinic after 6 months of onset of the illness and 15 (39.47%) eyes were blind at presentation.
Conclusion Glaucoma, hypertension and diabetes mellitus were the most common risk factors identified among study patients. A majority of patients had potentially blinding complications. There was also delay in presentation. Diagnostic and therapeutic facilities of the center should be improved to prevent vision loss from complications. People should be educated to seek health care immediately after the onset of visual symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted in full compliance with the 1964 Helsinki declaration on research involving human subjects. Prior to commencement of the study, ethical clearance was obtained from the Ethics Committee (Institutional Review Board) of University of Gondar.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
